WealthPlan Investment Management, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
WealthPlan Investment Management, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$55,926
-35.0%
78,493
-2.8%
0.00%
-33.3%
Q3 2022$86,000
+160.6%
80,786
+51.9%
0.01%
+200.0%
Q1 2022$33,00053,2000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders